KENVUE INC (1KVUE.MI) Stock Price & Overview
BIT:1KVUE • US49177J1025
Current stock price
The current stock price of 1KVUE.MI is 15.37 EUR. Today 1KVUE.MI is up by 2.03%.
1KVUE.MI Key Statistics
- Market Cap
- 29.46B
- P/E
- 16.53
- Fwd P/E
- 15.39
- EPS (TTM)
- 0.93
- Dividend Yield
- 4.76%
1KVUE.MI Stock Performance
1KVUE.MI Stock Chart
1KVUE.MI Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to 1KVUE.MI.
1KVUE.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to 1KVUE.MI. 1KVUE.MI has a medium profitability rating, but doesn't score so well on its financial health evaluation.
1KVUE.MI Earnings
On February 17, 2026 1KVUE.MI reported an EPS of 0.27 and a revenue of 3.78B. The company beat EPS expectations (19.68% surprise) and beat revenue expectations (0.69% surprise).
1KVUE.MI Forecast & Estimates
20 analysts have analysed 1KVUE.MI and the average price target is 17.19 EUR. This implies a price increase of 11.86% is expected in the next year compared to the current price of 15.37.
For the next year, analysts expect an EPS growth of 6.87% and a revenue growth 3.47% for 1KVUE.MI
1KVUE.MI Groups
Sector & Classification
1KVUE.MI Financial Highlights
Over the last trailing twelve months 1KVUE.MI reported a non-GAAP Earnings per Share(EPS) of 0.93. The EPS decreased by -5.26% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 9.72% | ||
| ROA | 5.43% | ||
| ROE | 13.66% | ||
| Debt/Equity | 0.72 |
1KVUE.MI Ownership
1KVUE.MI Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| OR | L'OREAL | 25.59 | 192.668B | ||
| LOR | L'OREAL | 25.59 | 192.588B | ||
| BEI | BEIERSDORF AG | 16.17 | 18.395B | ||
| ITP | INTERPARFUMS SA | 16.42 | 1.993B | ||
| ICOS | INTERCOS SPA | 15.82 | 1.168B | ||
| PHN | PHARMANUTRA SPA | 38.78 | 760.848M | ||
| ONTEX | ONTEX GROUP NV | 4.23 | 239.227M | ||
| ENV | ENERVIT | 15.06 | 74.76M | ||
| JBOG | JACQUES BOGART | N/A | 44.873M |
Related stock screener links
View all stocks in the Personal Care Products Industry | View all stocks in the Consumer Staples Sector | View all stocks on the Euronext Milan Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About 1KVUE.MI
Company Profile
Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. The company is headquartered in Summit, New Jersey and currently employs 21,780 full-time employees. The company went IPO on 2023-05-04. The Company’s differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, BAND-AID, Aveeno, Zyrtec, and Nicorette. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include pain care; cough, cold, and allergy; digestive health; smoking cessation; eye care; and other products. Self Care segments include brands such as Tylenol, Motrin, Nicorette, Benadryl, Zyrtec, Zarbee’s, ORSLTM, Rhinocort, and Calpol. The Skin Health and Beauty segment is focused on face and body care, as well as hair, sun, and other products. The Essential Health segment includes oral care, baby care, women’s health, wound care, and other products. Its portfolio includes Self Care, Skin Health and Beauty, and Essential Health products which connect with consumers across North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).
Company Info
IPO: 2023-05-04
KENVUE INC
1 Kenvue Way
Summit NEW JERSEY US
Employees: 21780
Phone: 19088741200
KENVUE INC / 1KVUE.MI FAQ
What does 1KVUE do?
Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. The company is headquartered in Summit, New Jersey and currently employs 21,780 full-time employees. The company went IPO on 2023-05-04. The Company’s differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, BAND-AID, Aveeno, Zyrtec, and Nicorette. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include pain care; cough, cold, and allergy; digestive health; smoking cessation; eye care; and other products. Self Care segments include brands such as Tylenol, Motrin, Nicorette, Benadryl, Zyrtec, Zarbee’s, ORSLTM, Rhinocort, and Calpol. The Skin Health and Beauty segment is focused on face and body care, as well as hair, sun, and other products. The Essential Health segment includes oral care, baby care, women’s health, wound care, and other products. Its portfolio includes Self Care, Skin Health and Beauty, and Essential Health products which connect with consumers across North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).
What is the current price of 1KVUE stock?
The current stock price of 1KVUE.MI is 15.37 EUR. The price increased by 2.03% in the last trading session.
What is the dividend status of KENVUE INC?
KENVUE INC (1KVUE.MI) has a dividend yield of 4.76%. The yearly dividend amount is currently 0.71.
What is the ChartMill rating of KENVUE INC stock?
1KVUE.MI has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
What is the employee count for 1KVUE stock?
KENVUE INC (1KVUE.MI) currently has 21780 employees.
What is the next earnings date for 1KVUE stock?
KENVUE INC (1KVUE.MI) will report earnings on 2026-05-06, before the market open.